Integra Lifesciences Holdings (STU:IL3) Days Sales Outstanding : 52.22 (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Integra Lifesciences Holdings Days Sales Outstanding?

Integra Lifesciences Holdings's average Accounts Receivable for the three months ended in Dec. 2024 was €242 Mil. Integra Lifesciences Holdings's Revenue for the three months ended in Dec. 2024 was €423 Mil. Hence, Integra Lifesciences Holdings's Days Sales Outstanding for the three months ended in Dec. 2024 was 52.22.

The historical rank and industry rank for Integra Lifesciences Holdings's Days Sales Outstanding or its related term are showing as below:

STU:IL3' s Days Sales Outstanding Range Over the Past 10 Years
Min: 50.17 Med: 60.84 Max: 66.63
Current: 58.57

During the past 13 years, Integra Lifesciences Holdings's highest Days Sales Outstanding was 66.63. The lowest was 50.17. And the median was 60.84.

STU:IL3's Days Sales Outstanding is ranked better than
59.46% of 814 companies
in the Medical Devices & Instruments industry
Industry Median: 65.99 vs STU:IL3: 58.57

Integra Lifesciences Holdings's Days Sales Outstanding declined from Dec. 2023 (59.89) to Dec. 2024 (52.22).

Integra Lifesciences Holdings Days Sales Outstanding Historical Data

The historical data trend for Integra Lifesciences Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integra Lifesciences Holdings Days Sales Outstanding Chart

Integra Lifesciences Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

70.10

52.21

56.33

62.81

59.08

Integra Lifesciences Holdings Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial															59.89	61.79	55.63	63.24	52.22

Competitive Comparison of Integra Lifesciences Holdings's Days Sales Outstanding

For the Medical Devices subindustry, Integra Lifesciences Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Integra Lifesciences Holdings's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integra Lifesciences Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Integra Lifesciences Holdings's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Integra Lifesciences Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Integra Lifesciences Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (237.803	+	260.113)	/	2 )	/	1538.053	*	365
=	248.958					/	1538.053	*	365
=	59.08

Integra Lifesciences Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (223.716	+	260.113)	/	2 )	/	422.727	*	365 / 4
=	241.9145					/	422.727	*	365 / 4
=	52.22

Integra Lifesciences Holdings (STU:IL3) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Integra Lifesciences Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Integra Lifesciences Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Integra Lifesciences Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integra Lifesciences Holdings Corp (STU:IL3) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

IART:USA IL3:Germany

Address

1100 Campus Road, Princeton, NJ, USA, 08540

Website

https://www.integralife.com

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Integra Lifesciences Holdings Headlines

No Headlines